19 results
10-K
2021 FY
EX-4.2
CADL
Candel Therapeutics Inc
29 Mar 22
Annual report
8:46am
of preferred stock may enable our board of directors to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest
S-3
CADL
Candel Therapeutics Inc
5 Aug 22
Shelf registration
5:08pm
by means of a merger, tender offer, proxy contest or otherwise. For example, if in the due exercise of its fiduciary obligations, our board of directors
10-Q
3balfpt0op66bt3
8 Sep 21
Quarterly report
8:37am
S-1/A
jr8l4ctwy3 o8mhp9lrx
16 Jul 21
IPO registration (amended)
6:07am
S-1
teis3 trc41
25 Jun 21
IPO registration
5:28pm
DRS/A
0n7h8
31 Mar 21
Draft registration statement (amended)
12:00am
424B4
49k1jdk5qsl l4npxwt
28 Jul 21
Prospectus supplement with pricing info
4:02pm
10-K
0zwrzev
29 Mar 22
Annual report
8:46am
- Prev
- 1
- Next